Illumina (ILMN) Stock: Buy, Sell, or Hold?
ILMN - Illumina Inc
$235.99
-54.07 (-18.64%)
▼
5d:
-12.41%
30d:
-11.19%
90d:
+19.09%
WAIT
LOW Confidence
Analysis Updated: Oct 30, 2026 12:00 AM ET
Earnings: Oct 29, 2026
0d
Get Alerted When ILMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ILMN is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ILMN is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$237.21
Based on 9.2% avg growth
INTRINSIC VALUE TODAY
$147.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ILMN is currently trading at $235.99, which is considered oversold relative to its 30-day fair value range of $256.98 to $282.18. From a valuation perspective, the stock is trading at a premium (Forward PE: 38.5) compared to its historical average (29.3). At these levels, the market is pricing in 9.5% annual earnings growth.
Technical Outlook: Technically, ILMN is in a strong uptrend. The price is currently testing key support at $231.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 18.6% recently.
Market Sentiment: ILMN scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ILMN is in a strong uptrend. The price is currently testing key support at $231.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 18.6% recently.
Market Sentiment: ILMN scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$256.98 -
$282.18
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.0%
Protect Your Profits
Holding ILMN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-18.6%)
- NEUTRAL: Near Wall St target ($248.90)
- BULLISH: Expecting earnings turnaround to 9.5% growth with 9.4% revenue growth
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$256.98 -
$282.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$231.18
Resistance Level
$294.21
Current Trend
Strong Uptrend
Technical data as of
Oct 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
38.51
Wall Street Target
$248.90
(+5.5%)
Revenue Growth (YoY)
9.4%
Earnings Growth (YoY)
-9.4%
Profit Margin
18.3%
Valuation Premium vs History
+9.5% premium
PE vs Historical
38.5 vs 29.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.5%
(market-implied from PE analysis)
1-Year Target
$258.41
(+10%)
2-Year Target
$282.96
(+20%)
3-Year Target
$309.84
(+31%)
3-Yr Target (if PE normalizes)
(PE: 39→29)
PE COMPRESSION
$235.73
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 38.5, Growth: 14.4%)
$353.20
(+50%)
Base:
(SPY PE: 19.9, Growth: 14.4%)
$182.14
(-23%)
Bear:
(PE: 16.9, Growth: 14.4%)
$154.82
(-34%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (54x PE), but valuation improves significantly next year (39x PE) as earnings recover.
Trailing PE: 54.12 | Current EPS (TTM): $5.36
Bull Case
$364.78
(+55%)
Analyst growth 14.3%, PE expands to 59.5
Base Case
$331.62
(+41%)
Market implied 14.3%, PE stable at 54.1
Bear Case
$197.24
(-16%)
Severe decline -20.0%, PE contracts to 46.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: November 01, 2026 3:21 AM ET
Data refreshes hourly during market hours. Next update: 4:21 AM
Data refreshes hourly during market hours. Next update: 4:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ILMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$751 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 38 SELL |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
21 analysts |
$303 | 54 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$259 | 45 HOLD |
Advanced ILMN Option Strategies
Professional options setups generated by AI based on today's ILMN price and gamma walls.
